Literature DB >> 26423113

Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC.

Kathleen Machiels1, João Sabino1, Leen Vandermosten1, Marie Joossens2,3,4, Ingrid Arijs1, Magali de Bruyn1, Venessa Eeckhaut5, Gert Van Assche1, Marc Ferrante1, Jan Verhaegen6, Kristel Van Steen7, Filip Van Immerseel5, Geert Huys8, Kristin Verbeke1, Albert Wolthuis1, Anthony de Buck Van Overstraeten1, Andre D'Hoore1, Paul Rutgeerts1, Séverine Vermeire1.   

Abstract

OBJECTIVE: Pouchitis is the most common complication after colectomy with ileal pouch-anal anastomosis (IPAA) for UC and the risk is the highest within the 1st year after surgery. The pathogenesis is not completely understood but clinical response to antibiotics suggests a role for gut microbiota. We hypothesised that the risk for pouchitis can be predicted based on the faecal microbial composition before colectomy.
DESIGN: Faecal samples from 21 patients with UC undergoing IPAA were prospectively collected before colectomy and at predefined clinical visits at 1 month, 3 months, 6 months and 12 months after IPAA. The predominant microbiota was analysed using community profiling with denaturing gradient gel electrophoresis followed by quantitative real-time PCR validation.
RESULTS: Cluster analysis before colectomy distinguished patients with pouchitis from those with normal pouch during the 1st year of follow-up. In patients developing pouchitis, an increase of Ruminococcus gnavus (p<0.001), Bacteroides vulgatus (p=0.043), Clostridium perfringens (p=0.011) and a reduction of two Lachnospiraceae genera (Blautia (p=0.04), Roseburia (p=0.008)) was observed. A score combining these five bacterial risk factors was calculated and presence of at least two risk factors showed a sensitivity and specificity of 100% and 63.6%, respectively.
CONCLUSIONS: Presence of R. gnavus, B. vulgatus and C. perfringens and absence of Blautia and Roseburia in faecal samples of patients with UC before surgery is associated with a higher risk of pouchitis after IPAA. Our findings suggest new predictive and therapeutic strategies in patients undergoing colectomy with IPAA. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  IBD BASIC RESEARCH; ILEOANAL POUCH; INFLAMMATORY BOWEL DISEASE; INTESTINAL BACTERIA; POUCHITIS

Mesh:

Substances:

Year:  2015        PMID: 26423113     DOI: 10.1136/gutjnl-2015-309398

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

Review 1.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  The gut microbiome: what every gastroenterologist needs to know.

Authors:  Benjamin H Mullish; Mohammed Nabil Quraishi; Jonathan P Segal; Gianluca Ianiro; Tariq H Iqbal
Journal:  Frontline Gastroenterol       Date:  2020-02-04

Review 3.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.

Authors:  Nathaniel Aviv Cohen; Nitsan Maharshak
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

4.  B cell superantigens in the human intestinal microbiota.

Authors:  Jeffrey J Bunker; Christoph Drees; Andrea R Watson; Catherine H Plunkett; Cathryn R Nagler; Olaf Schneewind; A Murat Eren; Albert Bendelac
Journal:  Sci Transl Med       Date:  2019-08-28       Impact factor: 17.956

Review 5.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 6.  Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.

Authors:  R Balfour Sartor; Gary D Wu
Journal:  Gastroenterology       Date:  2016-10-18       Impact factor: 22.682

7.  Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment.

Authors:  Hans Herfarth; Edward L Barnes; Millie D Long; Kim L Isaacs; Tom Leith; Michael Silverstein; Ylaine Gerardin; Zain Kassam
Journal:  Inflamm Intest Dis       Date:  2019-03-29

8.  Composite Sophora Colon-Soluble Capsule Ameliorates DSS-Induced Ulcerative Colitis in Mice via Gut Microbiota-Derived Butyric Acid and NCR+ ILC3.

Authors:  Ming-Jun Chen; Yang Feng; Lu Gao; Ming-Xiong Lin; Shi-da Wang; Zhan-Qi Tong
Journal:  Chin J Integr Med       Date:  2022-04-12       Impact factor: 1.978

Review 9.  The microbiome in inflammatory bowel diseases: from pathogenesis to therapy.

Authors:  Sheng Liu; Wenjing Zhao; Ping Lan; Xiangyu Mou
Journal:  Protein Cell       Date:  2020-06-29       Impact factor: 14.870

Review 10.  The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis.

Authors:  Jean-Frédéric LeBlanc; Jonathan P Segal; Lucia Maria de Campos Braz; Ailsa L Hart
Journal:  Nutrients       Date:  2021-05-23       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.